US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist

1.9150
+0.1750+10.06%

Trading Dec 26 13:03 ET

52.69MMarket Cap-0.96P/E (TTM)

Iterum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

71.16%-2.67M

11.44%-6.76M

-36.42%-13.08M

-112.91%-39.33M

-201.13%-12.84M

-104.12%-9.27M

-21.84%-7.63M

-181.64%-9.59M

-16.61%-18.47M

-73.44%-4.27M

Net income from continuing operations

-57.18%-6.09M

59.18%-5M

28.19%-7.1M

13.64%-38.37M

-142.87%-12.36M

86.68%-3.88M

-81.78%-12.24M

-182.54%-9.89M

51.47%-44.43M

-21.71%-5.09M

Operating gains losses

103.28%433K

-57.60%407K

-56.04%386K

-192.97%-11.06M

110.30%305K

-159.50%-13.2M

144.55%960K

116.96%878K

-80.49%11.89M

24.39%-2.96M

Depreciation and amortization

-98.17%8K

-98.39%7K

-2.78%1.75M

0.23%440K

-2.68%436K

-3.74%438K

-4.80%436K

-14.45%1.8M

-75.24%439K

Other non cash items

130.05%2.99M

-1.98%1.24M

-5.11%1.25M

10.44%5.95M

188.60%2.08M

-2.11%1.3M

-14.17%1.26M

-29.84%1.31M

-33.86%5.38M

-50.58%719K

Change In working capital

-101.23%-73K

-288.82%-3.48M

-185.22%-7.76M

19.56%2.76M

-197.54%-2.3M

3,023.68%5.94M

243.87%1.84M

-359.29%-2.72M

625.23%2.31M

1,319.17%2.35M

-Change in prepaid assets

-900.00%-1.35M

-12.85%-1.45M

115.64%226K

-105.54%-3.19M

-428.80%-628K

144.95%169K

17.00%-1.28M

-898.34%-1.45M

-253.87%-1.55M

137.60%191K

-Change in payables and accrued expense

-78.40%1.25M

-157.32%-1.74M

-516.39%-7.93M

12.44%5.71M

-183.97%-1.81M

371.38%5.77M

178.99%3.04M

-309.27%-1.29M

948.08%5.08M

2,658.97%2.15M

-Change in other current assets

----

--322K

----

--0

----

-Change in other current liabilities

-96.15%-102K

2.94%-99K

1.96%-100K

50.00%-354K

2.00%-98K

68.48%-52K

62.08%-102K

41.38%-102K

36.33%-708K

76.36%-100K

-Change in other working capital

----

-200.53%-189K

-57.02%49K

153.14%271K

----

133.87%188K

-73.30%114K

-288.19%-510K

-83.53%110K

Cash from discontinued investing activities

Operating cash flow

71.16%-2.67M

11.44%-6.76M

-36.42%-13.08M

-112.91%-39.33M

-201.13%-12.84M

-104.12%-9.27M

-21.84%-7.63M

-181.64%-9.59M

-16.61%-18.47M

-73.44%-4.27M

Investing cash flow

Cash flow from continuing investing activities

1,483.33%5.7M

-3.45%4.2M

41.23%7.21M

67.20%23.34M

208.89%13.52M

-97.73%360K

127.41%4.35M

-46.77%5.11M

125.56%13.96M

198.03%4.38M

Net PPE purchase and sale

--0

----

79.03%-13K

--0

142.86%3K

----

-1.64%-62K

-246.15%-45K

Net investment purchase and sale

1,496.64%5.7M

-3.76%4.2M

41.23%7.21M

66.55%23.35M

205.74%13.52M

-97.75%357K

127.53%4.36M

-46.77%5.11M

125.71%14.02M

199.33%4.42M

Cash from discontinued investing activities

Investing cash flow

1,483.33%5.7M

-3.45%4.2M

41.23%7.21M

67.20%23.34M

208.89%13.52M

-97.73%360K

127.41%4.35M

-46.77%5.11M

125.56%13.96M

198.03%4.38M

Financing cash flow

Cash flow from continuing financing activities

54,200.00%5.43M

-16.50%167K

2,971.06%7.22M

156.88%1.03M

36.03%589K

10K

200K

110.44%235K

-102.19%-1.82M

126.58%433K

Net issuance payments of debt

----

--0

----

65.45%-2.25M

--0

Net common stock issuance

54,200.00%5.43M

-16.50%167K

2,971.06%7.22M

138.80%1.03M

36.03%589K

--10K

--200K

--235K

-99.52%433K

--433K

Cash from discontinued financing activities

Financing cash flow

54,200.00%5.43M

-16.50%167K

2,971.06%7.22M

156.88%1.03M

36.03%589K

--10K

--200K

110.44%235K

-102.19%-1.82M

126.58%433K

Net cash flow

Beginning cash position

-63.61%5.01M

-55.99%7.42M

-71.10%6.11M

-23.21%21.13M

-76.40%4.85M

48.47%13.77M

-46.33%16.87M

-23.21%21.13M

85.68%27.51M

-42.98%20.55M

Current changes in cash

195.09%8.46M

22.37%-2.4M

131.65%1.35M

-136.19%-14.96M

132.42%1.27M

-178.66%-8.9M

86.06%-3.09M

-207.92%-4.25M

-149.91%-6.33M

106.38%546K

Effect of exchange rate changes

-21.74%-28K

-50.00%-18K

-125.00%-27K

-22.00%-61K

-151.85%-14K

17.86%-23K

55.56%-12K

45.45%-12K

-1,350.00%-50K

50.00%27K

End cash Position

177.11%13.44M

-63.61%5.01M

-55.99%7.42M

-71.10%6.11M

-76.40%4.85M

48.47%13.77M

-46.33%16.87M

-23.21%21.13M

Free cash flow

71.15%-2.67M

11.60%-6.76M

-36.42%-13.08M

-112.26%-39.34M

-197.98%-12.84M

-103.74%-9.26M

-21.90%-7.65M

-181.64%-9.59M

-16.55%-18.54M

-74.35%-4.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	71.16%-2.67M	11.44%-6.76M	-36.42%-13.08M	-112.91%-39.33M	-201.13%-12.84M	-104.12%-9.27M	-21.84%-7.63M	-181.64%-9.59M	-16.61%-18.47M	-73.44%-4.27M
Net income from continuing operations	-57.18%-6.09M	59.18%-5M	28.19%-7.1M	13.64%-38.37M	-142.87%-12.36M	86.68%-3.88M	-81.78%-12.24M	-182.54%-9.89M	51.47%-44.43M	-21.71%-5.09M
Operating gains losses	103.28%433K	-57.60%407K	-56.04%386K	-192.97%-11.06M	110.30%305K	-159.50%-13.2M	144.55%960K	116.96%878K	-80.49%11.89M	24.39%-2.96M
Depreciation and amortization	-98.17%8K	-98.17%8K	-98.39%7K	-2.78%1.75M	0.23%440K	-2.68%436K	-3.74%438K	-4.80%436K	-14.45%1.8M	-75.24%439K
Other non cash items	130.05%2.99M	-1.98%1.24M	-5.11%1.25M	10.44%5.95M	188.60%2.08M	-2.11%1.3M	-14.17%1.26M	-29.84%1.31M	-33.86%5.38M	-50.58%719K
Change In working capital	-101.23%-73K	-288.82%-3.48M	-185.22%-7.76M	19.56%2.76M	-197.54%-2.3M	3,023.68%5.94M	243.87%1.84M	-359.29%-2.72M	625.23%2.31M	1,319.17%2.35M
-Change in prepaid assets	-900.00%-1.35M	-12.85%-1.45M	115.64%226K	-105.54%-3.19M	-428.80%-628K	144.95%169K	17.00%-1.28M	-898.34%-1.45M	-253.87%-1.55M	137.60%191K
-Change in payables and accrued expense	-78.40%1.25M	-157.32%-1.74M	-516.39%-7.93M	12.44%5.71M	-183.97%-1.81M	371.38%5.77M	178.99%3.04M	-309.27%-1.29M	948.08%5.08M	2,658.97%2.15M
-Change in other current assets	----	----	----	--322K	----	----	----	----	--0	----
-Change in other current liabilities	-96.15%-102K	2.94%-99K	1.96%-100K	50.00%-354K	2.00%-98K	68.48%-52K	62.08%-102K	41.38%-102K	36.33%-708K	76.36%-100K
-Change in other working capital	----	-200.53%-189K	-57.02%49K	153.14%271K	----	----	133.87%188K	-73.30%114K	-288.19%-510K	-83.53%110K
Cash from discontinued investing activities
Operating cash flow	71.16%-2.67M	11.44%-6.76M	-36.42%-13.08M	-112.91%-39.33M	-201.13%-12.84M	-104.12%-9.27M	-21.84%-7.63M	-181.64%-9.59M	-16.61%-18.47M	-73.44%-4.27M
Investing cash flow
Cash flow from continuing investing activities	1,483.33%5.7M	-3.45%4.2M	41.23%7.21M	67.20%23.34M	208.89%13.52M	-97.73%360K	127.41%4.35M	-46.77%5.11M	125.56%13.96M	198.03%4.38M
Net PPE purchase and sale	--0	----	----	79.03%-13K	--0	142.86%3K	----	----	-1.64%-62K	-246.15%-45K
Net investment purchase and sale	1,496.64%5.7M	-3.76%4.2M	41.23%7.21M	66.55%23.35M	205.74%13.52M	-97.75%357K	127.53%4.36M	-46.77%5.11M	125.71%14.02M	199.33%4.42M
Cash from discontinued investing activities
Investing cash flow	1,483.33%5.7M	-3.45%4.2M	41.23%7.21M	67.20%23.34M	208.89%13.52M	-97.73%360K	127.41%4.35M	-46.77%5.11M	125.56%13.96M	198.03%4.38M
Financing cash flow
Cash flow from continuing financing activities	54,200.00%5.43M	-16.50%167K	2,971.06%7.22M	156.88%1.03M	36.03%589K	10K	200K	110.44%235K	-102.19%-1.82M	126.58%433K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	65.45%-2.25M	--0
Net common stock issuance	54,200.00%5.43M	-16.50%167K	2,971.06%7.22M	138.80%1.03M	36.03%589K	--10K	--200K	--235K	-99.52%433K	--433K
Cash from discontinued financing activities
Financing cash flow	54,200.00%5.43M	-16.50%167K	2,971.06%7.22M	156.88%1.03M	36.03%589K	--10K	--200K	110.44%235K	-102.19%-1.82M	126.58%433K
Net cash flow
Beginning cash position	-63.61%5.01M	-55.99%7.42M	-71.10%6.11M	-23.21%21.13M	-76.40%4.85M	48.47%13.77M	-46.33%16.87M	-23.21%21.13M	85.68%27.51M	-42.98%20.55M
Current changes in cash	195.09%8.46M	22.37%-2.4M	131.65%1.35M	-136.19%-14.96M	132.42%1.27M	-178.66%-8.9M	86.06%-3.09M	-207.92%-4.25M	-149.91%-6.33M	106.38%546K
Effect of exchange rate changes	-21.74%-28K	-50.00%-18K	-125.00%-27K	-22.00%-61K	-151.85%-14K	17.86%-23K	55.56%-12K	45.45%-12K	-1,350.00%-50K	50.00%27K
End cash Position	177.11%13.44M	-63.61%5.01M	-55.99%7.42M	-71.10%6.11M	-71.10%6.11M	-76.40%4.85M	48.47%13.77M	-46.33%16.87M	-23.21%21.13M	-23.21%21.13M
Free cash flow	71.15%-2.67M	11.60%-6.76M	-36.42%-13.08M	-112.26%-39.34M	-197.98%-12.84M	-103.74%-9.26M	-21.90%-7.65M	-181.64%-9.59M	-16.55%-18.54M	-74.35%-4.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data